True North acquires 3% in Biocon Biologics

▴ Biocon Biologics Logo
The leading private equity fund had earlier invested both in Biocon and its arm Syngene

True North has announced the acquisition of about 3% stake in Biocon Biologics India Ltd (BBIL), a wholly owned subsidiary of Biocon, for $100 million. The unlisted arm is now valued at approximately 25,000 crore in the market. This is the first stake dilution in Biocon Biologics since its formation in 2017.

Biocon is also in talks with other global investors such as Singapore government owned, Temasek Holdings and the UK government’s investment arm CDC for subsequent rounds. True North is also a likely participant in the process, it is learnt.

Biopharmaceutical firm, Biocon set up Biocon Biologics in December 2017 to house all its biologics business – biosimilars that include monoclonal antibodies, recombinant insulins and novel biologics – keeping future value unlocking in mind.

Tags : #bioconbiologics #truenorth #medicircle

About the Author

Team Medicircle

Related Stories

Loading Please wait...

Trending Now

China ropes in more countries for its COVID-19 vaccine trialsSeptember 29, 2020
Antarctica is still free of Covid-19. Can it stay that way?September 29, 2020
Over 200 travellers from India barred from Dubai flight over invalid Covid-19 testsSeptember 29, 2020
Netherland focuses on more stricker rule to comabt COVID-19 September 29, 2020
WHO aims to provide 120 Million rapid Coronavirus tests for poorer statesSeptember 29, 2020
UN chief on 1 Million COVID-19 deathsSeptember 29, 2020
Bahrain reports 585 Covid-19 cases, 777 recoveriesSeptember 28, 2020
Bringing hepatitis C testing and treatment to underserved communities in MadridSeptember 28, 2020
Polish doctor recovers from severe COVID-19 through rehabilitationSeptember 28, 2020
WHO supports rehabilitation of COVID-19 and other patients in UkraineSeptember 28, 2020
WHO work with migrant camps in Greece September 28, 2020
US employers being sued for COVID-19 infection spread September 28, 2020
Global Coronavirus deaths cross 1 Million markSeptember 28, 2020
Highly effective antibodies identified, may lead to passive COVID-19 vaccineSeptember 26, 2020
Europe has a lot of work to do to prevent COVID-19 transmission :WHOSeptember 26, 2020
Two million Coronavirus deaths : WHO September 26, 2020
Johnson & Johnson COVID-19 vaccine produces strong results September 26, 2020
New York to permanently switch to outdoor dining amid pandemicSeptember 26, 2020
WHO gave blessing for Coronavirus vaccine emergency use programme: ChinaSeptember 26, 2020
US surpasses 7 Million Coronavirus casesSeptember 26, 2020